BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18435778)

  • 1. Age-specific direct healthcare costs attributable to diabetes in a Swedish population: a register-based analysis.
    Wiréhn AB; Andersson A; Ostgren CJ; Carstensen J
    Diabet Med; 2008 Jun; 25(6):732-7. PubMed ID: 18435778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
    Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
    Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach.
    Bolin K; Gip C; Mörk AC; Lindgren B
    Diabet Med; 2009 Sep; 26(9):928-34. PubMed ID: 19719715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating disease prevalence using a population-based administrative healthcare database.
    Wiréhn AB; Karlsson HM; Carstensen JM
    Scand J Public Health; 2007; 35(4):424-31. PubMed ID: 17786807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The direct medical cost of diabetes in Israel.
    Chodick G; Heymann AD; Wood F; Kokia E
    Eur J Health Econ; 2005 Jun; 6(2):166-71. PubMed ID: 15690168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007.
    Köster I; Huppertz E; Hauner H; Schubert I
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):377-85. PubMed ID: 21264804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.
    Bruno G; Picariello R; Petrelli A; Panero F; Costa G; Cavallo-Perin P; Demaria M; Gnavi R
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):684-90. PubMed ID: 21907553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population.
    Sennfält K; Carlsson P; Thorfinn J; Frisk J; Henriksson M; Varenhorst E
    Scand J Urol Nephrol; 2003; 37(3):226-31. PubMed ID: 12775282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
    Ringborg A; Martinell M; Stålhammar J; Yin DD; Lindgren P
    Int J Clin Pract; 2008 May; 62(5):708-16. PubMed ID: 18355236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.
    Stock SA; Redaelli M; Wendland G; Civello D; Lauterbach KW
    Diabet Med; 2006 Mar; 23(3):299-305. PubMed ID: 16492214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a 'real world' routine healthcare setting: model based on the KORA Survey 2000.
    Icks A; Rathmann W; Haastert B; Gandjour A; Holle R; John J; Giani G;
    Diabet Med; 2007 May; 24(5):473-80. PubMed ID: 17381502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of heart failure in Swedish primary healthcare.
    Agvall B; Borgquist L; Foldevi M; Dahlström U
    Scand J Prim Health Care; 2005 Dec; 23(4):227-32. PubMed ID: 16272071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.
    Wettermark B; Hammar N; Fored CM; Leimanis A; Otterblad Olausson P; Bergman U; Persson I; Sundström A; Westerholm B; Rosén M
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):726-35. PubMed ID: 16897791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.
    Bilde L; Rud Svenning A; Dollerup J; Baekke Borgeskov H; Lange P
    Respir Med; 2007 Mar; 101(3):539-46. PubMed ID: 16889949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional variations and determinants of direct psychiatric costs in Sweden.
    Tiainen A; Edman G; Flyckt L; Tomson G; Rehnberg C
    Scand J Public Health; 2008 Jul; 36(5):483-92. PubMed ID: 18635731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical activity referrals in Swedish primary health care - prescriber and patient characteristics, reasons for prescriptions, and prescribed activities.
    Leijon ME; Bendtsen P; Nilsen P; Ekberg K; Ståhle A
    BMC Health Serv Res; 2008 Oct; 8():201. PubMed ID: 18828898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and gender differences in the impact of diabetes on the prevalence of ischemic heart disease: a population-based register study.
    Wiréhn AB; Ostgren CJ; Carstensen JM
    Diabetes Res Clin Pract; 2008 Mar; 79(3):497-502. PubMed ID: 18006174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.